⌘K

Login Start Free

Home/Filings/4/0001213900-25-118433

4//SEC Filing

Dillione Janet 4

Accession 0001213900-25-118433

CIK 0001410098other

View on SEC.gov Company Profile

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 9:30 PM ET

Size

15.7 KB

Accession

0001213900-25-118433

Insider Transaction Report

Form 4

Period: 2025-12-02

CorMedix Inc.CRMD

Director

Transactions

Exercise/Conversion
Common Stock
2025-12-02$4.03/sh+12,210$49,206→ 60,683 total
Exercise/Conversion
Common Stock
2025-12-02$4.43/sh+15,124$66,999→ 75,807 total
Exercise/Conversion
Common Stock
2025-12-02$3.55/sh+19,323$68,597→ 95,130 total
Sale
Common Stock
2025-12-02$10.00/sh−46,657$466,570→ 48,473 total
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-02−12,210→ 0 total
Exercise: $4.03Exp: 2032-02-22→ Common Stock (12,210 underlying)
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-02−15,124→ 0 total
Exercise: $4.43Exp: 2033-01-14→ Common Stock (15,124 underlying)
Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-02−19,323→ 5,000 total
Exercise: $3.55Exp: 2034-03-05→ Common Stock (19,323 underlying)

Footnotes (3)

[F1]These options were granted on 02/22/2022. These options are fully vested.
[F2]These options were granted on 01/14/2023. These options are fully vested.
[F3]These options were granted on 03/05/2024. These options are fully vested.

Documents

1 file

4
ownership.xmlPrimary

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1

filerCIK 0001489798

Filing Metadata

Form type: 4
Filed: Dec 3, 7:00 PM ET
Accepted: Dec 4, 9:30 PM ET
Size: 15.7 KB

View on SEC.gov